Events

Second Forum of the Mission adaptation to climate change
JUN
Tue
13
09:00 - 18:30

This was 2 years ago

Location

Online

Programmes
Climate, Energy, Mobility Missions

The European Commission is organising the Second Forum of the Mission adaptation to climate change.

The annual Forum will be the moment to take stock, identify issues, steer the Mission and define the path ahead.
 
This event was also organised last year. Recordings are available here
 
More details about registration will follow soon. 
 
The Mission Adaptation to Climate Change aims at supporting around 150 regions and communities in Europe towards reaching climate resilience by fostering the development of innovative solutions. Because climate change affects different regions, sectors of the economy and members of society in distinctive ways, the Mission will engage with the widest range of EU regional and local actors.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.